Drug Formulation with Cyclodextrins
Velesco is a niche contract research organization (CRO) specializing in early phase drug development. One of our core competencies is formulation of compounds for early toxicology studies. We take a targeted, scientific approach to pharmaceutical formulation.
One of our tools for formulation of poorly soluble early stage compounds is the family of cyclodextrins.
To learn more about how Velesco is utilizing cyclodextrins in early phase drug development, download our free whitepaper describing cyclodextrins and how they can be used as early stage solubilizers.
News and Events
Velesco will be exhibiting at the AAPS Annual Meeting
in San Diego, CA, Nov. 12-15, 2017
Come see us at booth 2706!
New materials handling laboratory has opened
at Velesco's Plymouth, MI facility!
Read the press release.
Velesco's work published in
a Drug Development & Delivery article!
Read it here.
Dave Barnes Featured in